Carisma Therapeutics Inc (CARM) Stock Price, Quote & News

Company Profile

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothel...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 491 6422

Website: www.carismatx.com

Address:

3675 Market Street, Suite 401, Philadelphia, United States

StockScanners Aug. 30 at 4:01 AM

$CARM alerted at $.24, ran to $.64🚨🚨🚨

0 · Reply

ibew358 Aug. 30 at 2:23 AM

$CARM BM

0 · Reply

Bullish6912 Aug. 30 at 2:07 AM

$CARM go create a new account, pumper bot. 😂

0 · Reply

Bullish6912 Aug. 30 at 2:05 AM

$CARM must be halted? Wtf are you talking about? Lol legit bot or retard

1 · Reply

dbr_island Aug. 30 at 1:34 AM

EPIC DAY BEFORE THE LONG WEEKEND 💸💰💸💰 If you’re reading this just know that there are opportunities to make LIFE CHANGING gains EVERY DAY Bull market, Bear market… it doesn’t matter This market lately is designed to have 100% runners almost consistently You just need to know how to play the game and be in the know BEFORE the crowd Been doing this for over 20 years so I understand market behavior Now I may not get it right every time all the time But you have seen the results I have changed my life Now my focus is YOU 🫵 I want to CHANGE lives I have changed many lives There is no feeling like it And I’m here to do it again I wish each one of you reading this a successful new year, and beyond ❤️ $CARM $NVVE $HWH $ULCC $LIMN enjoy the long weekend everyone. See you on Tuesday!

2 · Reply

jasko1 Aug. 30 at 1:22 AM

$CARM although I think this can make it above 1 dollar Monday if momentum continues. be careful if it doesn’t they already approved a reverse stock split anywhere between 1 for 10 & 1 for 50 per share as part of a broader strategy related to Carisma’s proposed merger with OrthoCellix Inc

1 · Reply

chartgenius779 Aug. 30 at 12:44 AM

$CARM buying dip Monday morning

1 · Reply

ibew358 Aug. 30 at 12:40 AM

$CARM

1 · Reply

M105 Aug. 30 at 12:38 AM

$CARM lol bye mr little peepee 🤣😂

1 · Reply

jmr1068204 Aug. 30 at 12:37 AM

$CARM Not half asleep me looking at the after-hours price wondering, "Huh...what happened? It stopped at just before 8pm. Must be halted." Lmao Enjoy the 3-day weekend everyone. We'll see what pops next week.

0 · Reply

Carisma Therapeutics Provides Corporate Updates

Feb 19, 2025, 7:30 AM EST - 6 months ago

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Feb 5, 2025, 7:30 AM EST - 7 months ago

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Dec 9, 2024, 8:30 AM EST - 9 months ago

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

MRNA

Nov 27, 2024, 7:30 AM EST - 9 months ago

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 17, 2024, 7:30 AM EST - 10 months ago

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

Nov 8, 2024, 7:30 AM EST - 10 months ago

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

MRNA

Nov 7, 2024, 7:30 AM EST - 10 months ago

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 5, 2024, 9:05 AM EST - 10 months ago

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

MRNA

Oct 30, 2024, 4:30 PM EDT - 10 months ago

Carisma Therapeutics Announces Changes to its Board of Directors

Oct 4, 2024, 9:05 AM EDT - 11 months ago

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

Sep 10, 2024, 7:30 AM EDT - 1 year ago

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

MRNA

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Present at Upcoming Conferences

Aug 8, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 6, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024

Aug 6, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

Jun 27, 2024, 4:30 PM EDT - 1 year ago

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Jun 25, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors

Jun 25, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

Jun 13, 2024, 4:30 PM EDT - 1 year ago

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

May 30, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

May 16, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

May 9, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 8, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

May 6, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

May 2, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

Apr 22, 2024, 4:35 PM EDT - 1 year ago

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Apr 1, 2024, 8:35 AM EDT - 1 year ago

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 21, 2024, 5:00 PM EDT - 1 year ago

Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Feb 28, 2024, 7:30 AM EST - 1 year ago

Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference

Dec 21, 2023, 7:00 AM EST - 1 year ago

Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 14, 2023, 7:00 AM EST - 1 year ago

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

MRNA

Nov 28, 2023, 7:00 AM EST - 1 year ago

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Nov 22, 2023, 7:30 AM EST - 1 year ago

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Nov 9, 2023, 7:30 AM EST - 1 year ago

Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Oct 31, 2023, 9:25 AM EDT - 1 year ago

Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC

Oct 25, 2023, 9:11 AM EDT - 2 years ago

Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023

Sep 5, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Investor Conferences

Sep 1, 2023, 8:30 AM EDT - 2 years ago

Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

Aug 24, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

Aug 10, 2023, 7:30 AM EDT - 2 years ago

Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Jun 28, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors

Jun 26, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes

Jun 14, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources

Jun 5, 2023, 7:30 AM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

May 30, 2023, 4:30 PM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

May 11, 2023, 7:30 AM EDT - 2 years ago

Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights

May 8, 2023, 4:30 PM EDT - 2 years ago

Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

May 5, 2023, 4:30 PM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

StockScanners Aug. 30 at 4:01 AM

$CARM alerted at $.24, ran to $.64🚨🚨🚨

0 · Reply

ibew358 Aug. 30 at 2:23 AM

$CARM BM

0 · Reply

Bullish6912 Aug. 30 at 2:07 AM

$CARM go create a new account, pumper bot. 😂

0 · Reply

Bullish6912 Aug. 30 at 2:05 AM

$CARM must be halted? Wtf are you talking about? Lol legit bot or retard

1 · Reply

dbr_island Aug. 30 at 1:34 AM

2 · Reply

jasko1 Aug. 30 at 1:22 AM

1 · Reply

chartgenius779 Aug. 30 at 12:44 AM

$CARM buying dip Monday morning

1 · Reply

ibew358 Aug. 30 at 12:40 AM

$CARM

1 · Reply

M105 Aug. 30 at 12:38 AM

$CARM lol bye mr little peepee 🤣😂

1 · Reply

jmr1068204 Aug. 30 at 12:37 AM

0 · Reply

Bullish6912 Aug. 30 at 12:37 AM

$CARM keep wanking…. 😂 dumba**

0 · Reply

M105 Aug. 30 at 12:35 AM

$CARM You couldn’t have picked a perfect gif that depicts you 🤣😂… I mean, you must have been drawn to this cos you look like it right? Deranged short looking for pennies.. try the pun shop next to your house.. o wait, you actually live on their stairway … retard!

0 · Reply

M105 Aug. 30 at 12:32 AM

$CARM Nope, you are a loose notion sucking on his balls at work 🤣😂.. Happy cleaning dummie..

0 · Reply

Bullish6912 Aug. 30 at 12:26 AM

$CARM back to.20c 😂

0 · Reply

Bullbear1010101 Aug. 30 at 12:20 AM

$CARM seems ok but quite the deop from about .66

1 · Reply

Kenrironworker Aug. 30 at 12:19 AM

$CARM it’s crazy some of these people enjoy the F out of people losing their money. That’s crazy to me.

1 · Reply

Bullish6912 Aug. 30 at 12:17 AM

$CARM keep wanking 😂 bro, you a bot?! or simply ret*rd???

0 · Reply

M105 Aug. 30 at 12:13 AM

$CARM ok little d** dude happy wanking till then.. dummy

0 · Reply

Bullish6912 Aug. 30 at 12:11 AM

$CARM fact you think it’s going any higher iss hilarious. Stfu see you Tuesday b*tch.

0 · Reply

M105 Aug. 30 at 12:10 AM

$CARM Closing over 100% ain’t nothing for you.. you dumb bears that think you’ll make a fortune shorting this.. happy miserable Tuesday

0 · Reply

promagictrade Aug. 30 at 12:09 AM

$CARM 3 days weekend that dip was expected, if you got some, just relax and wait for Tuesday.

0 · Reply

ibew358 Aug. 30 at 12:08 AM

$CARM how/why is this up 118% AH? Loving it, but anyone see news? I didn’t find anything yet. Have a great weekend!

0 · Reply

Market Cap	9.95M
Revenue (ttm)	19.63M
Net Income (ttm)	-60.48M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-308.10%
Debt to Equity Ratio	0.00

Volume	88,106,492
Avg Vol	2,805,604
Day's Range	N/A - N/A
Shares Out	41.79M
Stochastic %K	6%
Beta	1.79
Analysts	Sell
Price Target	$1.00